Upadacitinib - AbbVie
At a glance
- Drug Originator Abbott Laboratories
- Drug Class Amides; Anti-inflammatories; Antipsoriatics; Antirheumatics; Fluorocarbons; Imidazoles; Pyrazines; Pyrroles; Pyrrolidines; Skin disorder therapies; Small molecules; Vascular disorder therapies
- Mechanism of Action Janus kinase 1 inhibitors
- USA Patent Applicants ABBVIE
- USA Patents 49
- NDAs 1
- International Patents 193
- Patent Applications 202
Table of Contents
Disclaimer